Predicting drug synergy is essential for optimizing combination therapies in cancer treatment. Under extreme data scarcity, existing computational methods struggle to generalize to new cell lines. Although meta-learning approaches have shown promise, a critical limitation lies in their reliance on a unimodal Gaussian prior for task representation. In extreme few-shot settings, this assumption can overly pull the task posterior toward the prior mean, reducing the discriminability of task representations and pushing the model toward a generic mean-value predictor. To overcome this, we propose DiffPro, a novel framework that integrates a Latent Diffusion Model (LDM) as a structural prior. Unlike Gaussian-based methods, our diffusion module learns a flexible, data-driven prior that can model highly complex task distributions. This learned prior better reflects task heterogeneity in few-shot drug synergy prediction under extreme data scarcity, yielding more discriminative task representations. Comprehensive experiments on the DrugComb dataset demonstrate that DiffPro achieves a significant improvement in performance. Notably, in the challenging 5-shot setting, it outperforms the best-performing baseline, delivering approximately a 17.3% relative gain in R2 (0.264 vs. 0.225) and a 4.6% relative reduction in MSE. These results confirm that the diffusion prior successfully regularizes the latent space, mitigating task representation collapse and enabling robust, high-precision predictions for combination therapy design.
Shuting Jin, Xu Guo, Anqi Huang et al.· Proceedings of the 32nd ACM...· 0 citations
LLMBDC (Large Language Model for Biological Domains Oriented Clustering of Gene Ontology) provides a scalable, reproducible, and interpretable route to context-aware, system-level interpretation of GO enrichment results while preserving biological specificity.
Ximing Ran, Jie Xu, Peng Jin et al.· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.